BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

13.69

+2.15 (18.63%)

At close: Dec 5, 2025, 4:00 PM EST

13.75

+0.06 (0.44%)

After-hours: Dec 5, 2025, 7:48 PM EST

BBOT Employees

BridgeBio Oncology Therapeutics had 62 employees as of December 31, 2024.

Employees

62

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$1,853,774

Market Cap

1.10B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	62	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

BBOT News

17 days ago - BBOT to Participate in Upcoming December Investor Healthcare Conferences - GlobeNewsWire
23 days ago - BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewsWire
4 weeks ago - BBOT to Participate in the Jefferies Global Healthcare Conference in London - GlobeNewsWire
5 weeks ago - BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS) - GlobeNewsWire
5 weeks ago - Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglycemia - GlobeNewsWire
6 weeks ago - BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
7 weeks ago - BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
3 months ago - BBOT to Participate in Upcoming September Investor Healthcare Conferences - GlobeNewsWire